193 related articles for article (PubMed ID: 27725183)
1. Engineering Archeal Surrogate Systems for the Development of Protein-Protein Interaction Inhibitors against Human RAD51.
Moschetti T; Sharpe T; Fischer G; Marsh ME; Ng HK; Morgan M; Scott DE; Blundell TL; R Venkitaraman A; Skidmore J; Abell C; Hyvönen M
J Mol Biol; 2016 Nov; 428(23):4589-4607. PubMed ID: 27725183
[TBL] [Abstract][Full Text] [Related]
2. Using a fragment-based approach to target protein-protein interactions.
Scott DE; Ehebauer MT; Pukala T; Marsh M; Blundell TL; Venkitaraman AR; Abell C; Hyvönen M
Chembiochem; 2013 Feb; 14(3):332-42. PubMed ID: 23344974
[TBL] [Abstract][Full Text] [Related]
3. Full-length archaeal Rad51 structure and mutants: mechanisms for RAD51 assembly and control by BRCA2.
Shin DS; Pellegrini L; Daniels DS; Yelent B; Craig L; Bates D; Yu DS; Shivji MK; Hitomi C; Arvai AS; Volkmann N; Tsuruta H; Blundell TL; Venkitaraman AR; Tainer JA
EMBO J; 2003 Sep; 22(17):4566-76. PubMed ID: 12941707
[TBL] [Abstract][Full Text] [Related]
4. Interrogation of the protein-protein interactions between human BRCA2 BRC repeats and RAD51 reveals atomistic determinants of affinity.
Cole DJ; Rajendra E; Roberts-Thomson M; Hardwick B; McKenzie GJ; Payne MC; Venkitaraman AR; Skylaris CK
PLoS Comput Biol; 2011 Jul; 7(7):e1002096. PubMed ID: 21789034
[TBL] [Abstract][Full Text] [Related]
5. Divergent binding mode for a protozoan BRC repeat to RAD51.
Pantelejevs T; Hyvönen M
Biochem J; 2022 May; 479(10):1031-1043. PubMed ID: 35502837
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule inhibitors that target protein-protein interactions in the RAD51 family of recombinases.
Scott DE; Coyne AG; Venkitaraman A; Blundell TL; Abell C; Hyvönen M
ChemMedChem; 2015 Feb; 10(2):296-303. PubMed ID: 25470112
[TBL] [Abstract][Full Text] [Related]
7. A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death.
Scott DE; Francis-Newton NJ; Marsh ME; Coyne AG; Fischer G; Moschetti T; Bayly AR; Sharpe TD; Haas KT; Barber L; Valenzano CR; Srinivasan R; Huggins DJ; Lee M; Emery A; Hardwick B; Ehebauer M; Dagostin C; Esposito A; Pellegrini L; Perrior T; McKenzie G; Blundell TL; Hyvönen M; Skidmore J; Venkitaraman AR; Abell C
Cell Chem Biol; 2021 Jun; 28(6):835-847.e5. PubMed ID: 33662256
[TBL] [Abstract][Full Text] [Related]
8. A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor.
Lee M; Daniels MJ; Garnett MJ; Venkitaraman AR
Oncogene; 2011 Jul; 30(30):3360-9. PubMed ID: 21399666
[TBL] [Abstract][Full Text] [Related]
9. A variant of the breast cancer type 2 susceptibility protein (BRC) repeat is essential for the RECQL5 helicase to interact with RAD51 recombinase for genome stabilization.
Islam MN; Paquet N; Fox D; Dray E; Zheng XF; Klein H; Sung P; Wang W
J Biol Chem; 2012 Jul; 287(28):23808-18. PubMed ID: 22645136
[TBL] [Abstract][Full Text] [Related]
10. BRCA2 regulates DMC1-mediated recombination through the BRC repeats.
Martinez JS; von Nicolai C; Kim T; Ehlén Å; Mazin AV; Kowalczykowski SC; Carreira A
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3515-20. PubMed ID: 26976601
[TBL] [Abstract][Full Text] [Related]
11. Sequence fingerprints in BRCA2 and RAD51: implications for DNA repair and cancer.
Lo T; Pellegrini L; Venkitaraman AR; Blundell TL
DNA Repair (Amst); 2003 Sep; 2(9):1015-28. PubMed ID: 12967658
[TBL] [Abstract][Full Text] [Related]
12. Two modules in the BRC repeats of BRCA2 mediate structural and functional interactions with the RAD51 recombinase.
Rajendra E; Venkitaraman AR
Nucleic Acids Res; 2010 Jan; 38(1):82-96. PubMed ID: 19875419
[TBL] [Abstract][Full Text] [Related]
13. Improved RAD51 binders through motif shuffling based on the modularity of BRC repeats.
Lindenburg LH; Pantelejevs T; Gielen F; Zuazua-Villar P; Butz M; Rees E; Kaminski CF; Downs JA; Hyvönen M; Hollfelder F
Proc Natl Acad Sci U S A; 2021 Nov; 118(46):. PubMed ID: 34772801
[TBL] [Abstract][Full Text] [Related]
14. Valine 1532 of human BRC repeat 4 plays an important role in the interaction between BRCA2 and RAD51.
Ochiai K; Yoshikawa Y; Yoshimatsu K; Oonuma T; Tomioka Y; Takeda E; Arikawa J; Mominoki K; Omi T; Hashizume K; Morimatsu M
FEBS Lett; 2011 Jun; 585(12):1771-7. PubMed ID: 21601571
[TBL] [Abstract][Full Text] [Related]
15. Distinct binding of BRCA2 BRC repeats to RAD51 generates differential DNA damage sensitivity.
Chatterjee G; Jimenez-Sainz J; Presti T; Nguyen T; Jensen RB
Nucleic Acids Res; 2016 Jun; 44(11):5256-70. PubMed ID: 27084934
[TBL] [Abstract][Full Text] [Related]
16. BRCA2 BRC motifs bind RAD51-DNA filaments.
Galkin VE; Esashi F; Yu X; Yang S; West SC; Egelman EH
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8537-42. PubMed ID: 15937124
[TBL] [Abstract][Full Text] [Related]
17. Interaction with the BRCA2 C terminus protects RAD51-DNA filaments from disassembly by BRC repeats.
Davies OR; Pellegrini L
Nat Struct Mol Biol; 2007 Jun; 14(6):475-83. PubMed ID: 17515903
[TBL] [Abstract][Full Text] [Related]
18. A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition.
Trenner A; Godau J; Sartori AA
Mol Cancer Ther; 2018 Jul; 17(7):1392-1404. PubMed ID: 29654063
[TBL] [Abstract][Full Text] [Related]
19. The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51.
Carreira A; Hilario J; Amitani I; Baskin RJ; Shivji MK; Venkitaraman AR; Kowalczykowski SC
Cell; 2009 Mar; 136(6):1032-43. PubMed ID: 19303847
[TBL] [Abstract][Full Text] [Related]
20. Insights into DNA recombination from the structure of a RAD51-BRCA2 complex.
Pellegrini L; Yu DS; Lo T; Anand S; Lee M; Blundell TL; Venkitaraman AR
Nature; 2002 Nov; 420(6913):287-93. PubMed ID: 12442171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
